+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Portal Hypertension Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768187
  • Report
  • 101 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Chiasma Inc
  • Debiopharm Group
  • Dr. Falk Pharma GmbH
  • Galectin Therapeutics Inc
  • Genextra Spa
  • Gilead Sciences Inc
  • MORE
The global clinical trial report- “2019 Portal Hypertension Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Portal Hypertension. It presents in-depth analysis of Portal Hypertension clinical trials across markets and companies. The research work is for providing complete understanding into trends in Portal Hypertension.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Portal Hypertension clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Portal Hypertension

The research work is prepared through extensive and continuous research on Portal Hypertension trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Portal Hypertension patients are identified
  • The report includes panorama of Portal Hypertension clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Portal Hypertension clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Chiasma Inc
  • Debiopharm Group
  • Dr. Falk Pharma GmbH
  • Galectin Therapeutics Inc
  • Genextra Spa
  • Gilead Sciences Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Portal Hypertension Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Portal Hypertension Clinical Trials by Region
2.2.2 Average Enrollment of Portal Hypertension Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Portal Hypertension Treatment, 2019

3. Region wise Portal Hypertension Clinical Trials
3.1 Asia Pacific Portal Hypertension Clinical Trials by Country
3.2 Europe Portal Hypertension Clinical Trials by Country
3.3 North America Portal Hypertension Clinical Trials by Country
3.4 Middle East and Africa Portal Hypertension Clinical Trials by Country
3.5 South and Central America Portal Hypertension Clinical Trials by Country

4. Portal Hypertension Clinical Trial Trends
4.1 Start Year wise Portal Hypertension Clinical Trials
4.2 Phase wise Portal Hypertension Clinical Trials
4.3 Trial Status wise Portal Hypertension Clinical Trials
4.4 Trial Type wise Portal Hypertension Clinical Trials

5. Portal Hypertension Average Enrollment Trends
5.1 Average Enrollment in Portal Hypertension Trials by Year
5.2 Average Enrollment in Portal Hypertension Trials by Phase
5.3 Average Enrollment in Portal Hypertension Trials by Status
5.4 Average Enrollment in Portal Hypertension Trials by Type of Trial

6. Companies Participating in Portal Hypertension Clinical Trials
6.1 Portal Hypertension Trials by Sponsor Type
6.2 Portal Hypertension Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Portal Hypertension Trials- Phase 1
7.2 Portal Hypertension Trials- Phase 2
7.3 Portal Hypertension Trials- Phase 3
7.4 Portal Hypertension Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Portal Hypertension Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Portal Hypertension Clinical Trials and Enrolment
Figure 5: Europe - Country wise Portal Hypertension Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Portal Hypertension Clinical Trials and Enrolment
Figure 7: North America - Country wise Portal Hypertension Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Portal Hypertension Clinical Trials and Enrolment
Figure 9: Portal Hypertension Clinical Trials by Phase
Figure 10: Portal Hypertension Clinical Trials by Trial Status
Figure 11: Portal Hypertension Clinical Trials by Type
Figure 12: Portal Hypertension Clinical Trials by Sponsor Type
Figure 13: Portal Hypertension Clinical Trials by Leading Sponsors
Figure 14: Portal Hypertension Average Enrollment by Phase
Figure 15: Portal Hypertension Average Enrollment by Trial Status
Figure 16: Portal Hypertension Average Enrollment by Type
Figure 17: Portal Hypertension- Average Enrolment by Type of Sponsors
Figure 18: Portal Hypertension- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Portal Hypertension Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Portal Hypertension Clinical Trials and Enrolment
Table 5: Europe - Country wise Portal Hypertension Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Portal Hypertension Clinical Trials and Enrolment
Table 7: North America - Country wise Portal Hypertension Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Portal Hypertension Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Portal Hypertension Average Enrollment by Phase
Table 15: Portal Hypertension Average Enrollment by Trial Status
Table 16: Portal Hypertension Average Enrollment by Type
Table 17: Portal Hypertension- Average Enrolment by Type of Sponsors
Table 18: Portal Hypertension- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Chiasma Inc
  • Conatus Pharmaceuticals Inc
  • Debiopharm Group
  • Dr. Falk Pharma GmbH
  • Galectin Therapeutics Inc
  • Genextra Spa
  • Gilead Sciences Inc
  • MallInckrodt Plc
  • Novartis AG
  • United Therapeutics Corp
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4768187
Adroll
adroll